STOCK TITAN

Covetrus (CVET) Stock Price, News & Analysis

CVET NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
20 253 sessions, October 12, 2021 to October 12, 2022
Largest daily move
+10.5% close of May 6, 2022
1-year change
+13.3% closing prices, October 12, 2021 to October 12, 2022
1-month change
+0.7% closing prices, September 12, 2022 to October 12, 2022

Company Description

Covetrus Inc. is a global animal-health technology and services company that provides products, services, and technology for veterinary practices. The company describes its operating model as a single platform that connects veterinary practice partners with solutions and insights used in animal care and practice operations. Covetrus is headquartered in Portland, Maine, and its historical public-company ticker was CVET on Nasdaq.

The company’s business is centered on the veterinary community. Its offerings include animal-health products, practice services, prescription management capabilities, proprietary brands, and technology tools that support veterinarians, their practices, and patients. Covetrus has described its mission in terms of improving health and financial outcomes for veterinary practice partners by combining distribution, services, and technology into an integrated platform.

As a public company, Covetrus reported activity across geographic operating areas that included North America, Europe, and APAC & Emerging Markets. Company updates referenced demand for prescription management, adoption of its technology stack, growth of proprietary brands, and management of corporate costs as recurring operating themes. Its customer base and operating focus were global, with veterinary practices as the core end market.

The CVET ticker also represents a completed corporate-status history. Former holders of Covetrus common stock had their shares exchanged for cash on October 13, 2022, and later stockholder litigation materials referenced those former holders and the exchange of Covetrus securities. Subsequent company announcements continued to describe Covetrus as an animal-health technology and services company, while the CVET symbol remains a historical reference to the company’s former Nasdaq-listed public equity.

Stock Performance

$20.99
No recent trading
Last close: October 12, 2022
+13.3%
1 year to October 12, 2022

Covetrus (CVET) closed at $20.99 on October 12, 2022. In the 12 months to October 12, 2022, the price gained 13.3%.

See what a $1,000 investment in CVET was worth at its last close

CVET Metrics & Rankings

Price returns through October 12, 2022. Month and year figures include the first trading day. Ranking links may use different dates.

SEC Filings

No SEC filings available for CVET.

CVET Company Profile & Sector Positioning

Covetrus (CVET) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing CVET often look at related companies in the same sector, including McKesson Corporation (MCK), Henry Schein Inc (HSIC), Accendra Health, Inc. (ACH), Cencora, Inc. (COR), and 111, Inc. (YI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CVET's relative position within its industry.

Frequently Asked Questions

Covetrus (CVET) has no recent trading. Its last close was $20.99 on October 12, 2022.

Covetrus is an animal-health technology and services company that provides products, services, and technology for veterinary practices.

Covetrus serves veterinary practice partners, with offerings intended to support animal care, practice operations, and practice financial outcomes.

Covetrus has described its platform as combining animal-health products, services, prescription management, proprietary brands, and technology tools.

Covetrus is headquartered in Portland, Maine.

CVET was the Nasdaq ticker associated with Covetrus common stock before former holders had their shares exchanged for cash on October 13, 2022.

Covetrus reported public-company activity across geographic areas that included North America, Europe, and APAC & Emerging Markets.